Estònia -
estonià -
Ravimiamet
suvartar 80 mg õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - valsartaan - õhukese polümeerikattega tablett - 80mg 28tk; 80mg 20tk; 80mg 50tk; 80mg 56tk; 80mg 15tk; 80mg 90tk; 80mg 30tk; 80mg 7tk; 80mg 60tk
Unió Europea -
estonià -
EMA (European Medicines Agency)
semintra
boehringer ingelheim vetmedica gmbh - telmisartan - toimivad ained renin-angiotensiini süsteemi, angiotensiin ii antagonistid, tavaline - kassid - kroonilise neeruhaigusega (ckd) seotud proteinuuria vähendamine.
Estònia -
estonià -
Ravimiamet
valsacor õhukese polümeerikattega tablett
krka, d.d., novo mesto - valsartaan - õhukese polümeerikattega tablett - 320mg 28tk; 320mg 56tk; 320mg 84tk; 320mg 30tk; 320mg 20tk; 320mg 60tk; 320mg 90tk; 320mg 7tk
Unió Europea -
estonià -
EMA (European Medicines Agency)
cardalis
ceva santé animale - benazepril hydrochloride, spironolactone - sÜdame-veresoonkonna sÜsteem - koerad - ravi südamepuudulikkuse põhjustatud kroonilised degeneratiivsed valvulaarne haigus koertel (diureetikum toetusest, kui see on asjakohane).
Estònia -
estonià -
Ravimiamet
amodip närimistablett
ceva sante animale - amlodipiin - närimistablett - 1,25mg 200tk; 1,25mg 30tk; 1,25mg 100tk
Estònia -
estonià -
Ravimiamet
prilocard tablett
animedica gmbh - ramipriil - tablett - 5mg 28tk; 5mg 140tk
Estònia -
estonià -
Ravimiamet
prilocard tablett
animedica gmbh - ramipriil - tablett - 1,25mg 28tk; 1,25mg 140tk
Estònia -
estonià -
Ravimiamet
lodisure tablett
dechra regulatory b.v. - amlodipiin - tablett - 1mg 168tk; 1mg 56tk; 1mg 28tk
Unió Europea -
estonià -
EMA (European Medicines Agency)
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastilised ained - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.